INTRODUCTION
CTCF is a novel 11 Zn-finger transcription factor, present in nuclear extracts as a protein with an apparent MW of 130 kDa (CTCF-130) on SDS-PAGE. It was discovered for its ability to bind to an unusually long 45 bp GC-rich sequence containing three regularly spaced repeats of the core sequence CCCTC within the chicken c-myc promoter (1) . However, its ability to recognise diverged sequences by employing different combinations of zinc fingers has recently been demonstrated (2) . Since deregulation of the c-myc proto-oncogene is causally related to oncogenesis (3, 4) , identification and characterisation of factors regulating its transcription may provide insight into molecular mechanisms of normal and aberrant c-myc expression (3) (4) (5) (6) . Thus, CTCF features were further investigated (1,7) and its cDNA cloned (8) .
CTCF has been found to be expressed in different chicken tissues in multiple forms (130, 97, 80, 73, 70 and 55 kDa) as detected by anti-CTCF antibodies (8) . In various cell types the CTCF protein is encoded in a 4.1 kb mRNA, with the longest open reading frame (ORF) (2184 bp) of the cDNA predicting a 728 amino acid protein of 82 kDa. This contradicts the observed MW of 130 kDa. The discrepancy between the theoretical (82 kDa) and apparent (130 kDa) MWs of the CTCF protein products could be due to a number of possibilities: (i) there is an additional exon in the primary transcript, which is missing in our cDNA possibly generated by alternative splicing (9) (10) (11) (12) ; (ii) posttranslational modifications (13) (14) (15) (16) (17) (18) (19) could change the mobility of the CTCF protein; (iii) particular amino acid composition (20) (21) (22) (23) could lead to CTCF anomalous electrophoretic migration. These possibilities are discussed in this paper.
Of the other multiple forms of CTCF expressed, in this study we investigated the appearance of the 70 kDa protein. Previously, it was found that when the original CTCF cDNA containing the entire ORF and the 3′-untranslated region (3′-UTR) was expressed in cells, it produced the 70 kDa protein product, but not 82 or 130 kDa (8) . We investigated the following options for this discrepancy: (i) post-translational processing (24) (25) (26) or protein splicing (26) ; (ii) transcription and (iii) translation attenuation (27) (28) (29) .
In this study we show that that the discrepancy between the 82 and the 130 kDa MWs of the CTCF protein was due to anomalous migration in the SDS-PAGE (mechanism 3) and that the N-and C-terminal domains participate in this anomaly. We also show that the CTCF-70 protein represents a truncated version of the full length CTCF protein (CTCF-130), corresponding to the N-terminus, and is probably generated by premature termination of translation of the CTCF mRNA at a specific site within the CTCF coding region. This depends on the sequences within the UTRs and the coding region. Silent nucleotide substitution (i.e. mutation without changing the CTCF amino acid sequence) at the potential attenuator site inside the ORF restored the size of CTCF-70 to 130 kDa.
Additionally, we demonstrate that the 70 kDa protein, corresponding to the abnormally migrating CTCF N-terminal domain, enhanced transactivation induced by the full length wild type (wt) CTCF in COS6 cells.
MATERIALS AND METHODS

Recombinant plasmids
Plasmids pEEc and pBBc were constructed by inserting the full length 3.786 kb EcoRI-EcoRI fragment from plasmid p900-911 and the 3.647 kb EcoRI-EcoRI fragment from p900 (8) , respectively, into the eukaryotic expression vector pSG5, controlled by early SV40 promoter (Stratagene). pHHc was obtained by deleting a part of the 3′-UTR of pBBc with HindIII, resulting in a 2.855 kb insert (Fig. 1A) . 'PstI truncated' versions of all three plasmids (pBBc∆PP, pHHc∆PP and pEEc∆PP) were obtained by 'in-frame' PstI-PstI deletion of 840 bp within the coding sequences. pBBc, pHHc, pBBc∆PP, pHHc∆PP and pEEc∆PP myc-tagged derivatives were obtained by introducing a 294 bp (HincII-BamHI) fragment, encoding six myc tag epitopes, from the plasmid p6Myc Tags-D (30) into the MscI site at the 3′-terminal end of the CTCF ORF (Fig. 1A) . The pBBc-mut plasmid, containing point-mutations within the region of a proposed attenuator, was generated by PCR using two oligonucleotides beginning at nucleotide 385: 5′-TGATGATGGA-GCACCTGGAT-3′ and nucleotide 836: 5′-GAAGCTTACTC-TTCTTGTTCTTCTTGGTCTTCTTG-3′ (Fig. 1B) . Nucleotide numbers correspond to the 5′-end of the longest CTCF cDNA (8) . Mutated bases are shown underlined. The resulting mutated plasmid pBBc-mut was verified by sequencing. The reporter plasmid p90TKLuc was obtained by ligating the dimeric CTCF binding site (synthetic 90 oligomer) from the chicken c-myc promoter (-219 to -180 bp) (8) into the HindIII-XhoI site of the pTK Luciferase vector, based on pXp2 Luciferase vector (31) . N-and C-terminal domains of the CTCF protein (117-830 bp SmaI-HindIII fragment and 1908-3786 bp MscI-EcoRI fragment, respectively) were subcloned in frame into pGex 2TK (Pharmacia), generating pGST-N and pGST-C. The Zn-finger domain (541-2037 PvuII-EcoRI fragment from the p900 plasmid) was cloned into pGEX-3X (Pharmacia), generating pGST-Zn. Regions of DNA around the junctions were checked by sequencing.
Cells and transfections
COS6 cells were grown at low (40-50%) density in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum, and transfected with 1-10 µg of pBBc, pHHc or pEEc plasmids by the calcium phosphate precipitation method with 2× DNA precipitation buffer following the manufacturer's instructions ('5 Prime-3 Prime', Inc R , CP Laboratories, UK). Cell extracts were made 48 h post-transfection. For co-transfection assays 1.25 × 10 5 COS6 cells were plated in 16 mm dishes and 1 µg of reporter (p90TK Luc) and 0.5-2.5 µg of expressor (pHHc or pBBc) were introduced with Lipofectamine (2.5 µl/dish) following the manufacturer's instructions (Gibco BRL). The total amount of the DNA transfected was adjusted to 3.5 µg with the 'empty' pSG5 vector. Cells were harvested 16-18 h after transfection. Luciferase assays were performed with a 'Dual-Light TM ' kit (Tropix, USA) following the manufacturer's instructions using a TD-20e luminometer (Turner, USA).
Western blotting
Total cell lysates were treated with DNAse I in the presence of 5 mM MgCl 2 , electrophoresed on 10% SDS-PAGE gels, transferred onto Immobilon P membranes (Millipore, Bedford, MA) by semi-dry blotting, and probed with either the chicken-specific anti-CTCF antibody Ab2 (8) or monoclonal 9E10 anti-myc tag antibody (33) . CTCF or myc-tag-fusion proteins were visualized by the standard ECL procedure with an ECL detection system (Amersham).
In vitro translation
Aliquots of 1 µg of the pBBc, pEEc and pHHc DNA were translated in vitro using the TNT R coupled reticulocyte lysate system, according to the manufacturer's protocol (Promega) from the T7 promoter present in the pSG5 expression vector. The synthesised proteins were resolved on 10% SDS-PAGE gels, and blotted onto Immobilon-P membrane where necessary.
Protein preparation and molecular weight determination
The glutathione-S-transferase (GST)-fusions were expressed in TG-1 cells and purified on glutathione-Sepharose as previously described (32) , then to homogeneity by anion exchange FPLC using a mono-Q column (Pharmacia) and eluted at ∼0.2 M NaCl with a salt gradient (0.5-0.1 M) in a 20 mM Tris-HCl buffer pH 8.0. The purified GST-fusions were cleaved with thrombin, then treated sequentially with benzamidine beads (Sigma) and glutathioneSepharose (Pharmacia) to remove the protease and the GST, respectively. The molecular weight of the cleaved proteins was determined by comparing their mobility with that of Rainbow molecular weight markers (Amersham) after electrophoresis on 10% polyacrylamide-SDS gels. The cleaved proteins were also sequenced from their N-termini in order to confirm their identities. The true molecular weights were determined by matrix-assisted laser desorption mass spectrometry (MALD-MS) using the Finnigan Lasermat 200 mass spectrometer. The N-or C-portions of the CTCF protein were isolated by FPLC on a MonoQ column (Pharmacia), the protein samples were reduced with 20 mM dithiothreitol, desalted by HPLC on a C4 reverse phase column (Brownlee) with acetonitrile 0.1% trifluoroacetic acid. After chromatography the sample was dried under vacuum, taken up in 10% methanol, and then 0.5 ml was mixed with 0.5 ml of sinopinic acid matrix (10 mg/ml) solution in 70% acetonitrile on a slide following the manufacturer's instructions. The mass spectrometer was calibrated with bovine serum albumin (Sigma, M r = 66 430) for the uncleaved proteins and carbonic anhydrase II (Sigma, M r = 29.023) for the protein of molecular weight <30 000 Da. Each spectrum was determined at least three times and the mean values calculated.
RESULTS
The difference between the predicted (82 kDa) and apparent (130 kDa) molecular weights of the full length CTCF protein is due to aberrant migration of the N-and C-termini To explain the discrepancy between the predicted 82 and 130 kDa MWs of the CTCF protein, we first considered mechanism 1, i.e., the possibility of an additional exon in the primary transcript which is missing in the cDNA. All our investigations, including screening various cDNA libraries, RACE and RT-PCR on various total and polyA + mRNA preparations, failed to identify any additional coding sequences which could produce a 130 kDa form of CTCF protein. Therefore mechanism 1 was ruled out and the remaining options examined: mechanism 2, i.e. post-translational modifications of the protein and mechanism 3, i.e. CTCF-82 anomalous electrophoretic migration. In order to investigate these options, three parts of the CTCF cDNA (encoding the N-terminus, Zn-finger domain and C-terminus) were subcloned into pGex2TK vector (N-and C-termini) or pGex3T (Zn-finger domain). Recombinant GST-fusion proteins were expressed in Escherichia coli, purified and analysed by mass-spectrometry. Mass-spectrometry analysis did not reveal any post-translational modifications (mechanism 2). As shown in Table 1 , the experimental molecular weights of the GST-N fusion and N-and C-termini alone, determined by MALDI-MS, correspond well with their theoretical MWs. However, SDS-PAGE analysis demonstrated anomalous electrophoretic mobility of the GST-fusion proteins and the N-and C-termini. GST-Zn migrates as a 98 kDa protein in contrast to its predicted MW of 81.4 kDa (20% anomalous migration, Fig. 2A , lane 4). This fusion protein is rather unstable, giving rise to the products of degradation appearing as a smear after the staining with the anti-GST-antibodies. GST-C migrates as a 70 kDa protein, in contrast with its predicted size of 44 kDa (59% aberrant migration, Fig 3, respectively) . The SDS-PAGE gel was stained with Coomassie blue. Both the C-terminal and N-terminal domains migrate aberrantly at 35 and 70 kDa, respectively. The presence of the GST portion can, in some cases, be seen after the Coomassie staining (a band of ∼30 kDa, lane 2), otherwise it is easily detected by Western blotting with anti-GST antibodies (data not shown).
N-terminal domains are due to anomalous electrophoretic migration of the polypeptides (mechanism 3). This would in turn account for the anomalously high apparent molecular weight of the intact CTCF protein.
The 70 and 130 kDa forms of the CTCF protein are encoded within the same ORF of the CTCF cDNA
The problem of the considerable size difference between the CTCF-130 and CTCF-70 proteins still remained to be resolved. As shown in Figure 1A , the difference between pBBc which produced the 70 kDa protein and pHHc which produced the 130 kDa protein was only in the length of the 3′-UTR (also ref. 8). To investigate this further, pBBc, pHHc and an additional construct pEEc (CTCF cDNA of 3.786 kb which differs from pBBc in having an additional 106 bp of the 5′-UTR; Fig. 1A ) were expressed in vivo and in vitro. In vitro translation was carried out in the presence of [ 35 S]methionine. The 35 S-labelled protein products, made by rabbit reticulocyte lysates, and in vivo protein products from transfected COS6 cell lysates were electrophoresed on SDS-PAGE, blotted onto Immobilon-P membrane and autoradiographed (Fig. 3A, lanes 1-3, 4-6 respectively). The same membrane was then probed with the chicken-specific anti-CTCF antibody (8) (Fig. 3B) . pEEc, which represents the full length CTCF cDNA and pHHc which is missing parts of the 3′-and 5′-UTRs produced the CTCF-130 protein in both experiments (Fig. 3A , lanes 2 and 3; Fig. 3B lanes 2 and 3, 5 and 6 ). However, pBBc with full length 3′-UTR but missing 5′-UTR, generates a 70 kDa protein in both in vitro and in vivo experiments (Fig. 3A, lane 1 and Fig. 3B, lanes 1 and 4) . These results therefore showed that the ORF of the cloned cDNA was capable of encoding a protein that had the same electrophoretic mobility as the native protein (i.e. migrating at 130 kDa), but that a smaller protein (70 kDa) is made depending on the 5′-and 3′-UTRs of the cDNA insert. 
CTCF-70 is likely to be a product of premature termination of translation
In order to determine the origin of the 70 kDa CTCF protein, a sequence encoding six myc-tag epitopes was cloned in frame into the end of the CTCF Zn-finger domain of both plasmids-pBBc, producing the 70 kDa CTCF protein, and pHHc, producing the 130 kDa protein. As shown in Figure 4 , after transfection into COS6 cells both plasmids generate proteins which can be recognized by the chicken-specific antibody (Fig. 4A) . When the membrane was stripped of the anti-CTCF antibody and reprobed with the anti-myc tag antibody (9E10), only the product of pHHc-myc plasmid was positive, demonstrating that the p70 kDa protein is lacking the CTCF C-terminus (Fig. 4B) . (The appearence of the multiple bands in the pHHc myc-tagged plasmid is discussed below.)
Sequences responsible for generation of the CTCF-70 and CTCF-130
Analysis of sequences within the 3′-and 5′-UTRs affecting the size of the CTCF protein products, revealed that addition of only 106 bp (EcoRI-SmaI fragment, Fig. 1A ) of the 5′-UTR to the 3.672 kb cDNA (pBBc, Fig. 1A ), restored the size of the protein expressed in vivo and in vitro to 130 kDa (pEEc, Fig. 1A ). This fragment is very GC-rich (73% of GC-content, ref. 8) and its effect is specific. Thus, replacing it with other fragments (either GC-or AT-rich) did not change the size of the protein (70 kDa) produced from these hybrid cDNAs (data not shown). On the other hand, addition of a 792 bp of the 3′-UTR (HindIII-EcoRI fragment, pEEc, Fig. 1A ) to the plasmid pHHc-130, resulting in pBBc, reduced the apparent size of the protein made from 130 to 70 kDa. However, removal of this fragment from pEEc (pHHE, Fig. 1A ) did not change the size of the protein produced (130 kDa, data not shown). Thus, only particular combinations of the UTRs with sequences inside the coding region are responsible for the production of CTCF-70.
Deletion in the region containing the potential attenuator leads to production of the same size protein from pEEc, pHHc and pBBc
It has been noticed that the size of the 70 kDa protein corresponds to the size (68 kDa) of the CTCF N-terminal domain migrating abnormally (Fig. 1A, black arrow) . This, together with the observation that the C-terminal domain is missing in CTCF-70 (Fig. 4) , suggests the existence of a potential attenuation site within the coding region close to the end of the N-terminal domain with a likely position inside the sequence containing poly(A) stretches (Fig. 1B and ref. 8) . To locate the region in pBBc where premature termination of translation occurs the in-frame PstI-PstI deletion, which removes the putative attenuatior site, was obtained in all three plasmids, pBBc, pHHc and pEEc (Fig. 1A) . As shown in Figure 5A (lanes 1-3) , after transfection in COS6 cells, all three plasmids carrying the deletion produced a protein of the same size (97 kDa). This finding suggested the presence of the potential attenuator in pBBc within this deleted region. To further prove that this deletion does prevent translation termination and the C-terminal portions of all the proteins produced are intact, we employed the same 'myc-tag' approach as described above. For this purpose a sequence encoding six myc-tag epitopes was cloned in frame into the MscI site (the end of the Zn-finger domain) of all three plasmids (see also Materials and Methods and Fig. 1 ). As shown in Figure 5A (lanes 4-6) the three plasmids after transfection in COS6 cells and Western-immunoblot with the chicken-specific CTCF antibodies, produce proteins of the same size (∼110 kDa which corresponds to the size of the PstI-PstI deleted plasmids: 97 kDa plus the myc-tag component, 11 kDa). When the membrane was stripped of the anti-CTCF antibodies and reprobed with 9E10, the same bands appeared positive (Fig. 5B, lanes 4-6) . The multiple bands of smaller size observed in all our myc-tagged proteins (including pHHcmyc, Fig. 4A and B, lane 2) are not products of premature termination, but most likely resulted due to proteolysis of the myc-tagged proteins containing foreign sequences and therefore unstable because: (i) they are detected only with the 9E10 anti-myc-tag antibodies and not with the anti-N-terminal CTCF antibodies; (ii) they are specific only to the myc-tagged plasmids; and (iii) the same fragments can be seen in all three myc-tagged plasmids (Fig. 5B, lanes 4-6) . Thus the potential terminator of translation is very likely to be located within the PstI-PstI fragment and its removal prevents premature termination.
Point-mutations within the potential attenuator site restore the size of the CTCF-70 encoded in pBBc
To investigate whether the poly(A) sequences within the PstIPstI region are involved in attenuation, silent point-mutations were introduced into pBBc, creating pBBc-mut, such that they did not change the amino acid sequence, but at the same time disrupted the poly(A) stretches (Fig. 1B) . This alteration in the sequence restored the size of the protein expressed in vivo to 130 kDa (Fig. 5C, lane 3) suggesting the involvement of these poly(A)-stretches in premature termination.
CTCF-70 may enhance CTCF-130 mediated transactivation in COS6 cells
The ability of one single ORF to produce two alternative products both, in vivo and in vitro, raises a question of the CTCF-70's functional significance. CTCF-70 can be detected as a minor form in some cell types, but in bursa cells CTCF-70 represents ∼25% of the total CTCF proteins (8) . As CTCF-70 is correctly located in the nucleus (data not shown), efficiently expressed and corresponds to the CTCF N-terminal domain, one could expect that it may affect the normal function of 130 kDa protein. In fact, biological role of terminal fragments has been previously reported for some transcription factors. In particular, the C-terminal domain of p53 (34) (Fig. 6A) . Transactivation was dependent on the input of the expressor pHHc. As expected, no transactivation was observed with pBBc in the same assay (Fig. 6B) . However, CTCF-70 enhances the ability of CTCF-130 to transactivate the reporter when both expressors are present in COS6 cells (Fig. 6C) .
DISCUSSION
The major purpose of the experiments described above was to clarify the relationship between the native CTCF protein and those encoded and produced by the cloned cDNA. Evidence has been provided that: (i) the 130 kDa product is encoded in the 2184 bp ORF which predicts a 82 kDa protein; (ii) this discrepancy is due to an anomalous migration of the protein in the SDS-PAGE gel; (iii) the 70 kDa CTCF protein is a truncated version of CTCF-130 representing its N-terminal domain; and (iv) the 3′-, 5′-UTRs and sequences within the CTCF coding region affect the size of the expressed protein.
The 130 and 82 kDa proteins
The results in this paper demonstrate that the 82 kDa CTCF protein, encoded in the longest ORF of 2.184 kb, migrates as a protein with an apparent molecular weight of 130 kDa in SDS-PAGE, whether the recombinant protein was produced in vitro or in vivo. This corresponds to the apparent size of the endogenous native CTCF protein. We have also shown that the recombinant proteins are recognised by anti-CTCF antibodies demonstrating that the endogenous and recombinant proteins are identical. The aberrant mobility of the protein can be mainly accounted for by the electrophoretic mobility properties of the Nand C-terminal domains. The anomalous electrophoretic migration of the CTCF C-terminus may be explained by its high negative charge (26% acidic amino acids). Anomalous electrophoretic migration of negatively charged proteins is quite common and has been observed with proteins such as papillomavirus 16 E7 protein (20) and E.coli ams protein (36) . We also attempted to characterise the CTCF N-terminal domain aberrant migration. However, when pEH (Fig. 1A) was deleted up to the BamHI site and the resulting plasmid pBE expressed in COS6 cells, a 180% anomaly (21 kDa apparent versus 7.5 kDa theoretical MWs) was still observed. The reason for the anomalous migration of the N-terminal region remains unclear since there is no preponderance of particular types of amino acids.
The 130 and 70 kDa CTCF proteins
We have previously reported (8) that the original CTCF-expressing vectors based on the pBBc construct produced a nuclear protein with apparent molecular weight of 70 kDa in vivo and in vitro (Fig. 3) . The results of this paper demonstrate that: (i) CTCF-70 is a legitimate, not transient, protein product from pBBc since proteins with higher molecular weight from this construct have never been observed, and (ii) its size reduction is due to the loss of the C-terminal part of the CTCF protein. There are at least three possible mechanisms responsible for the appearance of the shorter protein: (i) post-translational processing/splicing of the full length protein; (ii) premature termination of transcription or RNA degradation; and (iii) premature termination of translation of the CTCF mRNA. Mechanism 1 can be ruled out since we were unable to detect a 130 kDa precursor from the pBBc plasmid, after conducting a variety of studies such as pulse-chase experiments, in vitro translation, and investigation of a stable cell line producing the 70 kDa protein (8, and unpublished data). Furthermore, proteolysis is considerably unlikely, as no additional bands were detected in extracts from pBBc myc-transfectants probed with 9E10 anti-myc antibodies (Fig. 4B) , and protein splicing is not applicable either, as the entire C-terminal (and, presumably, the Zn finger) domains are missing. Mechanism 2 can be excluded on the basis that with Northern blot analysis, we were unable to detect any additional RNA bands smaller than the 3.7 kb band, which corresponds to the full-length CTCF RNA in various tissues and cell lines including a stable cell line producing the 70 kDa protein (8) . Mechanism 3 is quite plausable, as three lines of evidence indicate that CTCF-70 is produced by premature termination of translation: (i) the entire C-terminal part of the CTCF-70 protein is missing as shown by the myc-tag approach (Fig. 4) ; (ii) deletion of the region incorporating the putative attenuator prevents premature termination of translation ( Fig. 5A and B); and (iii) point-mutation of the potential attenuator site restores the size of CTCF-70 to 130 kDa (Fig. 5C ).
Our investigations demonstrate that only particular combinations of the UTRs with sequences inside the coding region are responsible for the production of CTCF-70. Analysis of the 3′-UTR 792 bp sequence and the coding region revealed the presence of poly(T) and poly(A) stretches, respectively (8) . This implies the possibility of an attenuator produced by complementary interaction between the poly(T) and poly(A) stretches. The molecular basis of the production of the CTCF-70 is not known. However, based on data presented in this study and significant information accumulated in the understanding of the general translational termination processes (37) (38) (39) (40) (41) we have proposed a model for this mechanism. This model is the basis of ongoing and future investigations of this study and, therefore, seems relevant to this discussion. The involvement of the 5′-UTR and 3′-UTR in the regulation of translation has been convincingly established (29, 42, 43) . Much less is known about elements within coding regions which could contribute to this process. However, it has been shown that sequences within the coding region can affect the mRNA translation efficiency (44, 45) and translationally coupled mRNA degradation (46) . Our model of the molecular mechanism of premature termination involves both the UTRs and the coding region. In the case of pBBc composed of the ORF and 3′-UTR, the formation of the stem-loop secondary structure between the poly(T) sequences within the 3′-UTR and poly(A) stretches within the putative attenuator, could block the ribosome's passage through the CTCF mRNA. As a result a truncated protein product of 70 kDa is produced. In the case of pEEc, the additional GC-rich 5′-UTR sequences may cause a ribosome 'stalling' at the 5′-end of the CTCFmRNA. This 'stalling', in turn, can lead to destabilisation of the 'downstream' CTCFmRNA stem-loop structure allowing the ribosome to progress. pHHc, producing CTCF-130, is missing parts of its 5′-and 3′-UTRs. Thus, the pHHc mRNA may not have a developed secondary structure so that translation can be performed without spatial difficulties. This model is supported by the finding that the specific point mutations within the region of the potential attenuator in pBBc (CTCF-70) restored the size of the protein made to 130 kDa. It is likely that the introduced silent nucleotide substitutions altered particular stem-loop formation in the CTCF mRNA so that the ribosome could pass freely.
Functional significance of the 70 kDa protein
The 70 kDa protein may be functionally important and there are indications which make us believe that CTCF-70 does exist under normal physiological conditions. We showed previously that approximately a quarter of total CTCF proteins in bursa was represented by this form (8) and now we demonstrate that CTCF-70 can affect CTCF-130 transactivating capacity in COS6 cells (Fig. 6) . Since CTCF-70 does not have the DNA-binding and C-terminal domains, this apparent enhancement may result from the competition of the two forms for a common transcriptional repressor(s). CTCF-70 may have a similar role under normal physiological conditions (e.g. in lymphocytes) providing post-translational tuning of CTCF-130 normal function(s) by competition with interacting protein partners. Three proteins (p32, 80 and 97) have been specifically co-immuniprecipitated with CTCF-130 from COS6 cell extracts, however, one of them, p32, showed interaction with the N-terminal domain (E. Klenova, unpublished observations). A two-hybrid system in yeast is currently being employed to identify and clone other possible CTCF protein partners.
Previous investigations into the existence of the pBBc mRNA under normal physiological conditions included Northern blot analysis from various chicken cell lines and tissues. They revealed two closely migrating bands of ∼3.7 and 4.0 kb which are often impossible to resolve on agarose gels (8) . It is tempting to speculate that the smaller message corresponds to the mRNA with a part of its 5′-UTR missing (i.e., pBBc). Alternatively, this 'artificial' mRNA may serve as an appropriate substrate for the existent molecular apparatus responsible for the similar function in the cell. It seems very intriguing that a message with only 106 bp missing from the 5′-end produces a truncated protein. This may imply a translational control mechanism of protein production carried out by the mRNA itself. In our future studies we will attempt to fully elucidate the physiological significance of this message.
